Virax Biolabs Group Ltd SEC filings VRAX
Virax Biolabs Group Ltd has 159 filings in SEC EDGAR's recent list, going back to Dec 27, 2021. Its latest annual report, Form 20-F, was filed on Jul 6, 2026 for the period ended Mar 31, 2026. The most recent current report (Form 6-K) was filed on Oct 29, 2026. The company's fiscal year ends on March 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 6-K | Current report (foreign issuer) | Oct 29, 2026 | Oct 29, 2026 |
| 6-K | Current report (foreign issuer) | Oct 9, 2026 | Oct 9, 2026 |
| 424B3 | Prospectus | Sep 10, 2026 | — |
| 6-K | Current report (foreign issuer) | Sep 4, 2026 | Sep 4, 2026 |
| 424B5 | Prospectus supplement | Sep 4, 2026 | — |
| EFFECT | Filing | Sep 3, 2026 | — |
| F-3/A | Filing | Sep 2, 2026 | — |
| 6-K | Current report (foreign issuer) | Aug 26, 2026 | Aug 21, 2026 |
| 6-K | Current report (foreign issuer) | Aug 18, 2026 | Aug 18, 2026 |
| 6-K | Current report (foreign issuer) | Jul 31, 2026 | Jul 31, 2026 |
| F-3 | Shelf registration (foreign issuer) | Jul 24, 2026 | — |
| 6-K | Current report (foreign issuer) | Jul 16, 2026 | Jul 16, 2026 |
| 6-K | Current report (foreign issuer) | Jul 10, 2026 | Jul 10, 2026 |
| 6-K | Current report (foreign issuer) | Jul 9, 2026 | Jul 9, 2026 |
| 20-F | Annual report (foreign issuer) | Jul 6, 2026 | Mar 31, 2026 |
| 6-K | Current report (foreign issuer) | Jun 24, 2026 | Jun 24, 2026 |
| 6-K | Current report (foreign issuer) | Jun 12, 2026 | Jun 12, 2026 |
| 6-K | Current report (foreign issuer) | May 26, 2026 | May 26, 2026 |
| 6-K | Current report (foreign issuer) | May 22, 2026 | May 22, 2026 |
| 6-K | Current report (foreign issuer) | Apr 14, 2026 | Apr 14, 2026 |
| 6-K | Current report (foreign issuer) | Apr 10, 2026 | Apr 10, 2026 |
| 6-K | Current report (foreign issuer) | Mar 18, 2026 | Mar 18, 2026 |
| 6-K | Current report (foreign issuer) | Jan 30, 2026 | Jan 30, 2026 |
| 424B3 | Prospectus | Dec 31, 2025 | — |
| EFFECT | Filing | Dec 30, 2025 | — |
| CORRESP | Letter to the SEC | Dec 29, 2025 | — |
| F-3 | Shelf registration (foreign issuer) | Dec 18, 2025 | — |
| D | Filing | Dec 18, 2025 | — |
| 6-K | Current report (foreign issuer) | Dec 4, 2025 | Dec 4, 2025 |
| 6-K | Current report (foreign issuer) | Dec 2, 2025 | Dec 2, 2025 |
| 6-K | Current report (foreign issuer) | Jul 30, 2025 | Jul 30, 2025 |
| 20-F | Annual report (foreign issuer) | Jul 2, 2025 | Mar 31, 2025 |
| 6-K | Current report (foreign issuer) | Jun 13, 2025 | Jun 13, 2025 |
| 6-K | Current report (foreign issuer) | Mar 18, 2025 | Mar 18, 2025 |
| 6-K | Current report (foreign issuer) | Mar 13, 2025 | Mar 13, 2025 |
| 6-K | Current report (foreign issuer) | Mar 5, 2025 | Mar 5, 2025 |
| 6-K | Current report (foreign issuer) | Feb 25, 2025 | Feb 25, 2025 |
| S-8 | Employee stock plan registration | Jan 30, 2025 | — |
| 6-K | Current report (foreign issuer) | Dec 23, 2024 | Dec 23, 2024 |
| 6-K | Current report (foreign issuer) | Dec 17, 2024 | Dec 17, 2024 |
| 6-K | Current report (foreign issuer) | Dec 10, 2024 | Dec 10, 2024 |
| 6-K | Current report (foreign issuer) | Nov 20, 2024 | Nov 20, 2024 |
| 6-K | Current report (foreign issuer) | Oct 31, 2024 | Oct 31, 2024 |
| 6-K | Current report (foreign issuer) | Oct 23, 2024 | Oct 23, 2024 |
| 6-K | Current report (foreign issuer) | Sep 30, 2024 | Sep 30, 2024 |
| 424B5 | Prospectus supplement | Sep 30, 2024 | — |
| 6-K | Current report (foreign issuer) | Aug 23, 2024 | Aug 23, 2024 |
| 424B5 | Prospectus supplement | Aug 23, 2024 | — |
| 20-F | Annual report (foreign issuer) | Aug 20, 2024 | Mar 31, 2024 |
| NT 20-F | Filing | Aug 1, 2024 | Jul 31, 2024 |
| 6-K | Current report (foreign issuer) | Jun 11, 2024 | Jun 11, 2024 |
| 6-K | Current report (foreign issuer) | Apr 25, 2024 | Apr 25, 2024 |
| 6-K | Current report (foreign issuer) | Apr 16, 2024 | Apr 16, 2024 |
| 6-K | Current report (foreign issuer) | Mar 15, 2024 | Mar 15, 2024 |
| 6-K | Current report (foreign issuer) | Jan 22, 2024 | Jan 22, 2024 |
| 424B5 | Prospectus supplement | Jan 22, 2024 | — |
| 6-K | Current report (foreign issuer) | Jan 12, 2024 | Jan 11, 2024 |
| 6-K | Current report (foreign issuer) | Dec 21, 2023 | Dec 21, 2023 |
| 424B3 | Prospectus | Dec 20, 2023 | — |
| 6-K | Current report (foreign issuer) | Dec 20, 2023 | Dec 20, 2023 |
| 424B3 | Prospectus | Dec 20, 2023 | — |
| 6-K | Current report (foreign issuer) | Dec 18, 2023 | Dec 18, 2023 |
| EFFECT | Filing | Dec 15, 2023 | — |
| 6-K | Current report (foreign issuer) | Dec 14, 2023 | Dec 14, 2023 |
| CORRESP | Letter to the SEC | Dec 13, 2023 | — |
| UPLOAD | Letter from the SEC | Dec 12, 2023 | — |
| 6-K | Current report (foreign issuer) | Dec 8, 2023 | Dec 8, 2023 |
| F-3 | Shelf registration (foreign issuer) | Dec 5, 2023 | — |
| 6-K | Current report (foreign issuer) | Nov 8, 2023 | Nov 8, 2023 |
| 6-K | Current report (foreign issuer) | Oct 31, 2023 | Oct 31, 2023 |
| D | Filing | Oct 17, 2023 | — |
| 6-K | Current report (foreign issuer) | Oct 12, 2023 | Oct 12, 2023 |
| 6-K | Current report (foreign issuer) | Oct 4, 2023 | Oct 4, 2023 |
| 6-K | Current report (foreign issuer) | Sep 12, 2023 | Sep 12, 2023 |
| 6-K | Current report (foreign issuer) | Sep 1, 2023 | Sep 1, 2023 |
| 6-K | Current report (foreign issuer) | Aug 3, 2023 | Aug 3, 2023 |
| 6-K | Current report (foreign issuer) | Jul 18, 2023 | Jul 18, 2023 |
| 20-F | Annual report (foreign issuer) | Jun 14, 2023 | Mar 31, 2023 |
| 6-K | Current report (foreign issuer) | Jun 14, 2023 | Jun 14, 2023 |
| 6-K | Current report (foreign issuer) | May 4, 2023 | May 4, 2023 |
| 6-K | Current report (foreign issuer) | Apr 21, 2023 | Apr 21, 2023 |
| 6-K | Current report (foreign issuer) | Apr 19, 2023 | Apr 19, 2023 |
| 424B3 | Prospectus | Mar 31, 2023 | — |
| EFFECT | Filing | Mar 30, 2023 | — |
| CORRESP | Letter to the SEC | Mar 28, 2023 | — |
| UPLOAD | Letter from the SEC | Mar 28, 2023 | — |
| F-1 | Registration statement (foreign issuer) | Mar 22, 2023 | — |
| D | Filing | Mar 15, 2023 | — |
| 6-K | Current report (foreign issuer) | Mar 10, 2023 | Mar 10, 2023 |
| 6-K | Current report (foreign issuer) | Mar 7, 2023 | Mar 7, 2023 |
| 6-K | Current report (foreign issuer) | Feb 7, 2023 | Feb 7, 2023 |
| 6-K | Current report (foreign issuer) | Feb 2, 2023 | Feb 2, 2023 |
| 6-K | Current report (foreign issuer) | Feb 2, 2023 | Feb 2, 2023 |
| 6-K | Current report (foreign issuer) | Jan 4, 2023 | Jan 4, 2023 |
| 6-K | Current report (foreign issuer) | Dec 6, 2022 | Dec 6, 2022 |
| 424B3 | Prospectus | Dec 2, 2022 | — |
| EFFECT | Filing | Dec 1, 2022 | — |
| CORRESP | Letter to the SEC | Nov 29, 2022 | — |
| UPLOAD | Letter from the SEC | Nov 25, 2022 | — |
| F-1 | Registration statement (foreign issuer) | Nov 21, 2022 | — |
| 6-K | Current report (foreign issuer) | Nov 18, 2022 | Nov 18, 2022 |
| 6-K | Current report (foreign issuer) | Nov 15, 2022 | Nov 15, 2022 |
| 6-K | Current report (foreign issuer) | Nov 8, 2022 | Nov 8, 2022 |
| 6-K | Current report (foreign issuer) | Nov 3, 2022 | Nov 3, 2022 |
| 6-K | Current report (foreign issuer) | Oct 26, 2022 | Oct 26, 2022 |
| 6-K | Current report (foreign issuer) | Sep 22, 2022 | Sep 22, 2022 |
| 6-K | Current report (foreign issuer) | Sep 20, 2022 | Sep 20, 2022 |
| 6-K | Current report (foreign issuer) | Sep 12, 2022 | Sep 12, 2022 |
| 6-K | Current report (foreign issuer) | Sep 7, 2022 | Sep 7, 2022 |
| 20-F | Annual report (foreign issuer) | Aug 12, 2022 | Mar 31, 2022 |
| NT 20-F | Filing | Jul 29, 2022 | Mar 31, 2022 |
| 6-K | Current report (foreign issuer) | Jul 29, 2022 | Jul 29, 2022 |
| 6-K | Current report (foreign issuer) | Jul 26, 2022 | Jul 26, 2022 |
| 424B4 | Prospectus | Jul 21, 2022 | — |
| CERT | Filing | Jul 20, 2022 | — |
| FWP | Free writing prospectus | Jul 1, 2022 | — |
| EFFECT | Filing | Jun 30, 2022 | — |
| FWP | Free writing prospectus | Jun 30, 2022 | — |
| 8-A12B | For registration of certain classes | Jun 30, 2022 | — |
| CORRESP | Letter to the SEC | Jun 28, 2022 | — |
| CORRESP | Letter to the SEC | Jun 28, 2022 | — |
| F-1/A | Registration statement | Jun 27, 2022 | — |
| CORRESP | Letter to the SEC | Jun 24, 2022 | — |
| UPLOAD | Letter from the SEC | Jun 24, 2022 | — |
| CORRESP | Letter to the SEC | Jun 24, 2022 | — |
| F-1/A | Registration statement | Jun 24, 2022 | — |
| UPLOAD | Letter from the SEC | Jun 23, 2022 | — |
| CORRESP | Letter to the SEC | Jun 21, 2022 | — |
| F-1/A | Amendment no. 4 to form f-1 | Jun 21, 2022 | — |
| UPLOAD | Letter from the SEC | Jun 16, 2022 | — |
| F-1/A | Registration statement | Jun 7, 2022 | — |
| CORRESP | Letter to the SEC | May 11, 2022 | — |
| F-1/A | Registration statement | May 11, 2022 | — |
| UPLOAD | Letter from the SEC | May 5, 2022 | — |
| F-1/A | Registration statement | Apr 25, 2022 | — |
| CORRESP | Letter to the SEC | Apr 22, 2022 | — |
| UPLOAD | Letter from the SEC | Apr 7, 2022 | — |
| CORRESP | Letter to the SEC | Mar 18, 2022 | — |
| F-1 | Registration statement (foreign issuer) | Mar 18, 2022 | — |
| UPLOAD | Letter from the SEC | Mar 10, 2022 | — |
| DRSLTR | Filing | Feb 17, 2022 | — |
| DRS/A | Filing | Feb 17, 2022 | — |
| UPLOAD | Letter from the SEC | Jan 28, 2022 | — |
| DRS | Filing | Dec 27, 2021 | — |
Showing 144 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- In Vitro & In Vivo Diagnostic Substances (SIC 2835)
- Listed as
- VRAX (Nasdaq)
- Fiscal year ends
- March 31
- Incorporated in
- Cayman Islands
- Headquarters
- Lanarkshire, United Kingdom
- SEC filer status
- Non-accelerated filer, Emerging growth company
- SEC CIK
- 1885827
- Former names
- Virax Biolabs (Cayman) Ltd (until Dec 27, 2021)
Other In Vitro & In Vivo Diagnostic Substances companies
- Idexx Laboratories Inc /DE IDXX
- Lantheus Holdings, Inc. LNTH
- Neogen Corp NEOG
- Celldex Therapeutics, Inc. CLDX
- Intellia Therapeutics, Inc. NTLA
- QuidelOrtho Corp QDEL
- Achieve Life Sciences, Inc. ACHV
- Myriad Genetics Inc MYGN
Source: SEC EDGAR filings. This is company-reported data, not investment advice.